Delivery Order SPE2DB22D3501-SPE2DB25FVB67

Award Date 3/27/25
Potential Completion Date 4/17/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $24,446.28 firm fixed-price contract is for the delivery of 240 mg/24 ml vials of the drug Opdivo. The order has an ultimate completion date of November 3, 2023. AmerisourceBergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,743.80 firm fixed-price delivery order is for 240 mg/24 ml vials of the drug Opdivo, with a period of performance through November 28, 2023. The contract is not designated as a set-aside and represents an award under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $19,875.72 firm fixed-price contract provides the DLA with 240 mg/24 ml vials of the drug Opdivo for a period ending on March 26, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $98,689.50, is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract has an ultimate completion date of August 9, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the prescription drug Opdivo (240 mg/24 ml vial). The firm-fixed-price, $15,294.80 delivery order contract has a completion date of July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as...
This federal contract award is a delivery order worth $47,470.20 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract has an ultimate completion date of December 23, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo (nivolumab) 240 mg/24 ml vial. The order, valued at $91,768.80, is a firm fixed-price contract with an ultimate completion date of August 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,875.72 delivery order is for OPDIVO 240 MG/24 ML VIAL 24ML and has a firm fixed price. The contract has an ultimate completion date of February 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, SPE2DX15D1022|SPE2DX24FVMTE, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $95,592.50 firm fixed-price delivery order is for the supply of 240 mg/24 mL vials of the cancer drug Opdivo. The contract has an ultimate completion date of September 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,823.40 Firm Fixed Price Delivery Order covers the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialized pharmaceutical product. The contract has an ultimate completion date of December 26, 2024 and was awarded on December 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVB67
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,689.30, is for the supply of 240 mg/24 ml vials of the drug Opdivo to support federal healthcare programs. The contract has an ultimate completion date of April 17, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/26/25, 9:52 AM